Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of September 8, 2026, CARL trades at $15.25 with a market cap of $425.92M and a P/E ratio of -7.20. CARL moved -2.31% today. Year to date, CARL is +23.32%; over the trailing twelve months it is +13.83%. Its 52-week range spans $8.50 to $17.23. Analyst consensus is strong buy with an average price target of $19.50. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CARL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CARL recently traded at $15.25. Market cap is $425.92M. P/E ratio is -7.20. Revenue is $50.51M.
| Metric | Value |
|---|---|
| Price | $15.25 |
| Market Cap | $425.92M |
| P/E Ratio | -7.20 |
| EPS | $-2.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.23 |
| 52-Week Low | $8.50 |
| Volume | 50.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $50.51M |
| Net Income | $-29.63M |
| Gross Margin | 75.31% |
5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.50.